Cargando…

Coronavirus disease 2019 (COVID-19): a clinical update

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It caused a total of 80 868 confirmed cases and 3101 deaths in Chinese mainland until March 8, 2020. This novel virus spread mainly through resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Min, Zhang, Xinxin, Qu, Jieming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115348/
https://www.ncbi.nlm.nih.gov/pubmed/32240462
http://dx.doi.org/10.1007/s11684-020-0767-8
_version_ 1783514077354524672
author Zhou, Min
Zhang, Xinxin
Qu, Jieming
author_facet Zhou, Min
Zhang, Xinxin
Qu, Jieming
author_sort Zhou, Min
collection PubMed
description Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It caused a total of 80 868 confirmed cases and 3101 deaths in Chinese mainland until March 8, 2020. This novel virus spread mainly through respiratory droplets and close contact. As disease progressed, a series of complications tend to develop, especially in critically ill patients. Pathological findings showed representative features of acute respiratory distress syndrome and involvement of multiple organs. Apart from supportive care, no specific treatment has been established for COVID-19. The efficacy of some promising antivirals, convalescent plasma transfusion, and tocilizumab needs to be investigated by ongoing clinical trials.
format Online
Article
Text
id pubmed-7115348
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Higher Education Press
record_format MEDLINE/PubMed
spelling pubmed-71153482020-04-02 Coronavirus disease 2019 (COVID-19): a clinical update Zhou, Min Zhang, Xinxin Qu, Jieming Front Med Review Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. It caused a total of 80 868 confirmed cases and 3101 deaths in Chinese mainland until March 8, 2020. This novel virus spread mainly through respiratory droplets and close contact. As disease progressed, a series of complications tend to develop, especially in critically ill patients. Pathological findings showed representative features of acute respiratory distress syndrome and involvement of multiple organs. Apart from supportive care, no specific treatment has been established for COVID-19. The efficacy of some promising antivirals, convalescent plasma transfusion, and tocilizumab needs to be investigated by ongoing clinical trials. Higher Education Press 2020-04-02 2020 /pmc/articles/PMC7115348/ /pubmed/32240462 http://dx.doi.org/10.1007/s11684-020-0767-8 Text en © Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Zhou, Min
Zhang, Xinxin
Qu, Jieming
Coronavirus disease 2019 (COVID-19): a clinical update
title Coronavirus disease 2019 (COVID-19): a clinical update
title_full Coronavirus disease 2019 (COVID-19): a clinical update
title_fullStr Coronavirus disease 2019 (COVID-19): a clinical update
title_full_unstemmed Coronavirus disease 2019 (COVID-19): a clinical update
title_short Coronavirus disease 2019 (COVID-19): a clinical update
title_sort coronavirus disease 2019 (covid-19): a clinical update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115348/
https://www.ncbi.nlm.nih.gov/pubmed/32240462
http://dx.doi.org/10.1007/s11684-020-0767-8
work_keys_str_mv AT zhoumin coronavirusdisease2019covid19aclinicalupdate
AT zhangxinxin coronavirusdisease2019covid19aclinicalupdate
AT qujieming coronavirusdisease2019covid19aclinicalupdate